VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 362 filers reported holding VANECK VECTORS ETF TR in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -97.8% | 100 | -97.5% | 0.00% | -100.0% |
| Q4 2017 | $92,000 | 0.0% | 3,987 | 0.0% | 0.01% | -6.7% |
| Q3 2017 | $92,000 | +58.6% | 3,987 | +51.8% | 0.02% | +15.4% |
| Q2 2017 | $58,000 | -9.4% | 2,627 | -6.2% | 0.01% | -7.1% |
| Q1 2017 | $64,000 | +4.9% | 2,800 | -3.4% | 0.01% | +27.3% |
| Q4 2016 | $61,000 | -20.8% | 2,900 | 0.0% | 0.01% | -21.4% |
| Q3 2016 | $77,000 | – | 2,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |